A HUMAN-MILK FACTOR INHIBITS BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS TO THE CD4 RECEPTOR

被引:71
作者
NEWBURG, DS
VISCIDI, RP
RUFF, A
YOLKEN, RH
机构
[1] HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115
[2] JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT INFECT DIS,BALTIMORE,MD 21205
[3] JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,BALTIMORE,MD 21205
关键词
D O I
10.1203/00006450-199201000-00004
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Perinatal transmission of human immunodeficiency virus (HIV) from infected mothers to their children occurs at rates reported as 20-50%. The role of breast feeding in perinatal transmission of viral infections has not been well established. We studied 34 milk and colostral samples obtained from HIV-seropositive and HIV-seronegative women to determine if they contained anti-HIV activity. We found that all the samples contained a factor that inhibited the binding of HIV epitope-specific MAb to recombinant CD4 receptor molecules. The titers of inhibitory activity ranged from 1:200 to 1:10 000 and did not differ between HIV-seropositive and HIV-seronegative mothers. This milk factor also inhibited the binding of gp120 to CD4. Neither human sera nor bovine milk exhibited appreciable inhibitory activity. Fractionation of human milk indicated that the inhibitory activity was confined to the macromolecular fraction; little activity was found in isolated milk lipids or oligosaccharides. Chromatographic procedures indicated that the active macromolecule has an isoelectric point of 9.3-9.6. The active material did not bind to concanavalin A; however, the activity was partially destroyed by chemical and enzymatic treatments that removed sulfated residues. The active material may thus be a sulfated protein, glycoprotein, mucin, or glycosaminoglycan that inhibits the binding of CD4 to HIV envelope glycoproteins. The role of this factor in the natural history of HIV infection in infants and children should be the subject of additional investigations.
引用
收藏
页码:22 / 28
页数:7
相关论文
共 60 条
  • [1] INHIBITION OF ATTACHMENT OF STREPTOCOCCUS-PNEUMONIAE AND HAEMOPHILUS-INFLUENZAE BY HUMAN-MILK AND RECEPTOR OLIGOSACCHARIDES
    ANDERSSON, B
    PORRAS, O
    HANSON, LA
    LAGERGARD, T
    SVANBORGEDEN, C
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (02) : 232 - 237
  • [2] ANDO Y, 1987, JPN J CANCER RES, V78, P322
  • [3] NOVEL SULFATED POLYSACCHARIDES - DISSOCIATION OF ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITY FROM ANTITHROMBIN ACTIVITY
    BABA, M
    DECLERCQ, E
    SCHOLS, D
    PAUWELS, R
    SNOECK, R
    VANBOECKEL, C
    VANDEDEM, G
    KRAAIJEVELD, N
    HOBBELEN, P
    OTTENHEIJM, H
    DENHOLLANDER, F
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (02) : 208 - 213
  • [4] ANTIGENICITY AND IMMUNOGENICITY OF DOMAINS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ENVELOPE POLYPEPTIDE EXPRESSED IN THE YEAST SACCHAROMYCES-CEREVISIAE
    BARR, PJ
    STEIMER, KS
    SABIN, EA
    PARKES, D
    GEORGENASCIMENTO, C
    STEPHANS, JC
    POWERS, MA
    GYENES, A
    VANNEST, GA
    MILLER, ET
    HIGGINS, KW
    LUCIW, PA
    [J]. VACCINE, 1987, 5 (02) : 90 - +
  • [5] DESIGNING CD4 IMMUNOADHESINS FOR AIDS THERAPY
    CAPON, DJ
    CHAMOW, SM
    MORDENTI, J
    MARSTERS, SA
    GREGORY, T
    MITSUYA, H
    BYRN, RA
    LUCAS, C
    WURM, FM
    GROOPMAN, JE
    BRODER, S
    SMITH, DH
    [J]. NATURE, 1989, 337 (6207) : 525 - 531
  • [6] PROTECTION OF SUCKLING MICE FROM THE HEAT-STABLE ENTERO-TOXIN OF ESCHERICHIA-COLI BY HUMAN-MILK
    CLEARY, TG
    CHAMBERS, JP
    PICKERING, LK
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1983, 148 (06) : 1114 - 1119
  • [7] COCKLE SA, 1978, J BIOL CHEM, V253, P8019
  • [8] CUNNINGAM AS, 1979, J PEDIATR, V94, P685
  • [9] MORBIDITY IN BREAST-FED AND ARTIFICIALLY FED INFANTS
    CUNNINGHAM, AS
    [J]. JOURNAL OF PEDIATRICS, 1977, 90 (05) : 726 - 729
  • [10] CUSSEN GH, 1980, TOPICS PERINATAL MED, P79